Plain-English translation of NCT07405021 on ClinicalTrials.gov β Β· Source last updated Β· Translation generated Β· How we translate trials
This study doesn't follow the usual testing phases β it may be an observational study or a different type of research.
This trial is testing transcutaneous vagus nerve stimulation (tVNS)βa gentle, non-invasive treatment that stimulates a major nerve in your neck through your earβas a way to reduce pain from diabetic nerve damage. You would receive this treatment along with traditional physical therapy, five times per week for six weeks. The study aims to see if this treatment can reduce pain intensity, improve nerve function, and help you move and function better in daily life.
Diabetic nerve damage causes persistent pain, numbness, and weakness that seriously affects quality of life, and current pain medications often come with troubling side effects. This trial exists to find a non-drug treatment option that could help people manage this pain and improve their ability to do everyday activities without relying on medications that may cause other problems.
You likely qualify ifβ¦
You likely don't qualify ifβ¦
You would attend sessions five days per week for six weeks. In each session, you would receive 30 minutes of traditional physical therapy plus 30 minutes of vagus nerve stimulation (or placebo stimulation if you're in the comparison group). The nerve stimulation is applied through a small device placed on your ear and is non-invasive and painless. During the six-week study period, your pain levels, nerve function, and ability to walk and perform daily activities would be measured and compared.
AI-generated summary from trial data Β· Jun 10, 2026 Β· Not medical advice
Egypt